Active 0 6 0 6 O
in 7 9 7 9 O
care 10 14 10 14 O
is 15 17 15 17 O
defined 18 25 18 25 O
as 26 28 26 28 O
having 29 35 29 35 O
at 36 38 36 38 O
least 39 44 39 44 O
two 45 48 45 48 B-lower_bound
clinical 49 57 49 57 O
visits 58 64 58 64 O
in 65 67 65 67 O
the 68 71 68 71 O
past 72 76 72 76 O
year 77 81 77 81 O

All 0 3 82 85 O
participants 4 16 86 98 O
who 17 20 99 102 O
have 21 25 103 107 O
a 26 27 108 109 O
FDA 28 31 110 113 O
contraindication 32 48 114 130 O
or 49 51 131 133 O
cautions 52 60 134 142 O
for 61 64 143 146 O
nicotine 65 73 147 155 B-allergy_name
lozenge 74 81 156 163 I-allergy_name
use 82 85 164 167 O
( 86 87 168 169 O
pregnancy 87 96 169 178 B-pregnancy
, 96 97 178 179 O
breastfeeding 98 111 180 193 O
, 111 112 193 194 O
recent 113 119 195 201 O
cardiovascular 120 134 202 216 B-chronic_disease
distress 135 143 217 225 I-chronic_disease
, 143 144 225 226 O
or 145 147 227 229 O
phenylketonuria 148 163 230 245 B-chronic_disease
) 163 164 245 246 O

All 0 3 247 250 O
patients 4 12 251 259 O
already 13 20 260 267 O
on 21 23 268 270 O
NRT 24 27 271 274 B-treatment

The 0 3 275 278 O
Food 4 8 279 283 O
and 9 12 284 287 O
Drug 13 17 288 292 O
Administration 18 32 293 307 O
( 33 34 308 309 O
FDA 34 37 309 312 O
) 37 38 312 313 O
advises 39 46 314 321 O
caution 47 54 322 329 O
for 55 58 330 333 O
nicotine 59 67 334 342 B-treatment
lozenge 68 75 343 350 I-treatment
use 76 79 351 354 O
among 80 85 355 360 O
women 86 91 361 366 B-gender
who 92 95 367 370 O
are 96 99 371 374 B-pregnancy
pregnant 100 108 375 383 I-pregnancy

individuals 0 11 384 395 O
18 12 14 396 398 B-lower_bound
years 15 20 399 404 I-lower_bound
and 21 24 405 408 O
older 25 30 409 414 O

women 0 5 415 420 B-gender
who 6 9 421 424 O
are 10 13 425 428 O
pregnant 14 22 429 437 B-pregnancy
at 23 25 438 440 O
the 26 29 441 444 O
time 30 34 445 449 O
of 35 37 450 452 O
baseline 38 46 453 461 O

